Data gathered: July 11
AI Stock Analysis - LabCorp (LH)
Analysis generated October 23, 2024. Powered by Chat GPT.
Laboratory Corporation of America Holdings, commonly known as LabCorp, is an American healthcare company that operates one of the largest clinical laboratory networks in the world. The company offers a broad range of diagnostic services, including tests for various diseases and medical conditions. LabCorp's services are essential for both healthcare providers and patients, providing critical data to guide treatment decisions.
Stock Alerts - LabCorp (LH)
 |
LabCorp | July 11 Ro Khanna (member of U.S. congress) is selling shares |
|
LabCorp | July 3 Insider Alert: ANDERSON KERRII B is selling shares |
|
LabCorp | June 13 Insider Alert: ANDERSON KERRII B is selling shares |
|
LabCorp | June 6 Insider Alert: Caveney Brian J is selling shares |
Download our app to get future alerts delivered in real-time.
Alternative Data for LabCorp
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 2,000 | Sign up | Sign up | Sign up |
| Sentiment | N/A | Sign up | Sign up | Sign up |
| Webpage traffic | 15,141,000 | Sign up | Sign up | Sign up |
| Employee Rating | 70 | Sign up | Sign up | Sign up |
| Google Trends | 93 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 74 | Sign up | Sign up | Sign up |
| Facebook Followers | 14,427 | Sign up | Sign up | Sign up |
| Instagram Followers | 13,285 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 2 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 2,071 | Sign up | Sign up | Sign up |
| Twitter Followers | 8,136 | Sign up | Sign up | Sign up |
| Twitter Mentions | N/A | Sign up | Sign up | Sign up |
| Youtube Subscribers | 6,270 | Sign up | Sign up | Sign up |
| News Mentions | 1 | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 63 | Sign up | Sign up | Sign up |
| Linkedin Employees | 39,994 | Sign up | Sign up | Sign up |
About LabCorp
Laboratory Corp. of America Holdings is a clinical laboratory company, which engages in the provision of clinical laboratory and end-to-end drug development services. It operates through the LabCorp Diagnostics and Covance Drug Development segments. The LabCorp Diagnostics segment includes core testing as well as genomic and esoteric testing. The Covance Drug Development segment involves in providing drug development solutions, to companies in the pharmaceutical and biotechnology industries.
| Price | $249.62 |
| Target Price | Sign up |
| Volume | 1,020,000 |
| Market Cap | $21.7B |
| Year Range | $211.6 - $264.26 |
| Dividend Yield | 1.1% |
| PE Ratio | 29.85 |
| Analyst Rating | 89% buy |
| Earnings Date | July 24 '25 |
| Industry | Health Care Services |
In the news
 |
Labcorp Holdings Inc. (NYSE:LH) Receives $276.08 Average PT from BrokeragesJuly 11 - ETF Daily News |
|
Principal Financial Group Inc. Has $22.11 Million Stock Position in Labcorp Holdings Inc. (NYSE:LH)July 10 - ETF Daily News |
|
Labcorp Holdings Inc. (NYSE:LH) Shares Acquired by D.A. Davidson & CO.July 7 - ETF Daily News |
|
DAVENPORT & Co LLC Sells 269 Shares of Labcorp Holdings Inc. (NYSE:LH)July 7 - ETF Daily News |
|
Vontobel Holding Ltd. Trims Stock Position in Labcorp Holdings Inc. (NYSE:LH)July 7 - ETF Daily News |
|
Amalgamated Bank Grows Position in Labcorp Holdings Inc. (NYSE:LH)July 4 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '25 | 3.35B | 2.4B | 948M | 213M | 498M | 3.840 |
| Q4 '24 | 3.33B | 2.43B | 896M | 143M | 418M | 3.450 |
| Q3 '24 | 3.28B | 2.38B | 904M | 169M | 423M | 3.500 |
| Q2 '24 | 3.22B | 2.36B | 864M | 205M | 463M | 3.940 |
| Q1 '24 | 3.18B | 2.34B | 837M | 228M | 478M | 3.680 |
Insider Transactions View All
| ANDERSON KERRII B filed to sell 12,166 shares at $265. July 2 '25 |
| ANDERSON KERRII B filed to sell 12,666 shares at $260. June 12 '25 |
| Caveney Brian J filed to sell 30,067 shares at $247. June 5 '25 |
| Schechter Adam H filed to sell 98,962 shares at $248.7. May 13 '25 |
| Wilkinson Peter J filed to sell 2,054 shares at $242.3. May 5 '25 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Ro Khanna |
Jul 10, 25 | Sell | $1K - $15K |
| Rob Bresnahan |
Jun 2, 25 | Buy | $1K - $15K |
| Gil Cisneros |
Apr 8, 25 | Sell | $1K - $15K |
Read more about LabCorp (LH) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of LabCorp?
The Market Cap of LabCorp is $21.7B.
What is LabCorp's PE Ratio?
As of today, LabCorp's PE (Price to Earnings) ratio is 29.85.
When does LabCorp report earnings?
LabCorp will report its next earnings on July 24 '25.
What is the current stock price of LabCorp?
Currently, the price of one share of LabCorp stock is $249.62.
How can I analyze the LH stock price chart for investment decisions?
The LH stock price chart above provides a comprehensive visual representation of LabCorp's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling LabCorp shares. Our platform offers an up-to-date LH stock price chart, along with technical data analysis and alternative data insights.
Does LH offer dividends to its shareholders?
Yes, LabCorp (LH) offers dividends to its shareholders, with a dividend yield of 1.1%. This dividend yield represents LabCorp's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering LabCorp in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of LabCorp?
Some of the similar stocks of LabCorp are Abbott Laboratories, HCA Healthcare, Cardinal Health, Henry Schein, and Idexx Laboratories.
.